Evidence map›Paper›PMID 32776601›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2020

Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients.

Diego Santos-García, Mila Oreiro, Patricia Pérez, Gemma Fanjul, Jose Manuel Paz González, María José Feal Painceiras, Carlos Cores Bartolomé, Lorena Valdés Aymerich, Carlos García Sancho, Maria Del Mar Castellanos Rodrigo

3 registry-linked trialsOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 40 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 6 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04651478 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Mental Representation Techniques Targeting Pain in Parkinson´s Disease Patients: A Randomized Controlled Trial

TypeinterventionalSponsorUniversidad Francisco de VitoriaRan2021 to 2021Enrolled32ConditionsParkinson Disease, PainArmsAction Observation+Motor Imagery through BCI, Action Observation through non-related with movement illustrations
NCT04651699 nacompletednot on this mapstarted 2021, after this paper: background citation

Non-Invasive Brain Stimulation Targeting Pain in Parkinson´s Disease Patients: A Randomized Controlled Trial

TypeinterventionalSponsorUniversidad Francisco de VitoriaRan2021 to 2023Enrolled22ConditionsParkinson Disease, PainArmsActive Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation
NCT06214377 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Transcranial Direct Current Stimulation (tDCS) on Pain Modulation in Individuals With Parkinson's Disease in the Off State

TypeinterventionalSponsorUniversidad Francisco de VitoriaRan2023 to 2024Enrolled15ConditionsParkinson Disease, PainArmsActive Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation, Dopaminergic medication
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 6 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Parkinson's disease and COVID-19: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  4. Pooled it
  5. COVID-19 and Parkinson's Disease: What Do We Know So Far?Journal of Parkinson's disease · 2021
    Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Non-invasive Brain Stimulation for Central Neuropathic Pain.Frontiers in molecular neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Diego Santos-GarcíaDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Mila OreiroAsociación Parkinson Galicia - Coruña, A Coruña, Spain.
Patricia PérezFederación Española de Parkinson, Madrid, Spain.
Gemma FanjulFederación Española de Parkinson, Madrid, Spain.
Jose Manuel Paz GonzálezDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
María José Feal PainceirasDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Carlos Cores BartoloméDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Lorena Valdés AymerichDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Carlos García SanchoDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Maria Del Mar Castellanos RodrigoDepartment of Neurology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Complexo Hospitalario Universitario A Coruña · ESFederación Española de Enfermedades Raras · ESGerontologic Complex La Milagrosa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to know the impact of the coronavirus disease 2019 (COVID-19) pandemic on Spanish patients with Parkinson's disease (PD).

methodsThis is a descriptive, observational, cross-sectional study. An anonymous online survey with 95 questions was distributed among patients. Responses were collected from 11 May 2020 to 20 July 2020.

resultsOf a total of 570 questionnaires received, 568 (99.6%) were considered valid for the analysis (mean age, 63.5 ± 12.5 years; 53% females). A total of 553 patients (97.4%) were aware of the COVID-19 pandemic and 68.8% were concerned about it; 95.6% took preventive measures. A total of 484 patients (85.2%) had no contact with cases of COVID-19, and only 15 (2.6%) had confirmed COVID-19. Although up to 72.7% remained active during confinement, 65.7% perceived a worsening of their symptoms.

conclusionsSpanish patients with PD perceived the COVID-19 pandemic with concern and responsibility. More than half experienced worsening of their symptoms during confinement. © 2020 International Parkinson and Movement Disorder Society.

Indexed as

Coronavirus InfectionsDisease ProgressionPandemicsPneumonia, ViralAgedBetacoronavirusCOVID-19Cross-Sectional StudiesFemaleHumansMaleMiddle AgedParkinson DiseaseSARS-CoV-2SpainSurveys and QuestionnairesconfinementCOVID-19impactpandemicParkinson's disease

Identifiers

PMID32776601
PMCPMC7436468
OpenAlexW3048353066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.